Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial

Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06167-8. Online ahead of print.

Søren Gullaksen^{1

2

3}, Liv Vernstrøm^{4

5}, Steffen S Sørensen^{4

5}, Steffen Ringgaard⁶, Christoffer Laustsen⁶, Kristian L Funck⁷, Per L Poulsen^{4

7}, Esben Laugesen^{5

7

8}

¹ Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. soegul@clin.au.dk.
² Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. soegul@clin.au.dk.
³ Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark. soegul@clin.au.dk.
⁴ Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
⁵ Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
⁶ Department of Clinical Medicine, The MR Research Centre, Aarhus University, Aarhus, Denmark.
⁷ Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
⁸ Diagnostic Centre, Silkeborg Regional Hospital, Silkeborg, Denmark.

No abstract available

Publication types